Note: Ingredients listed on restricted chemical lists
EC/CAS
200-289-5/56-81-5
Name of the chemical
glycerol
Concentration
>=30-<60
General Information
Version
8.6
Revision date
2024-06-21
Product name
mPAGE 4X LDS Sample Buffer, 10 mL
1.2.1 Relevant identified uses
Biochemical research/analysis
Emergency telephone
+60 (0)3-74943688, +60 (0)3-74910850, +60 3- 9212 5794
Icons in SDS
Company Information
company name
Merck Sdn. Bhd
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H318
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Classification according to CLASS regulations 2013 GHS Classification Classification according to CLASS regulations 2013 Skin corrosion/irritation (Category 2), H315 Serious eye damage/eye irritation (Category 1), H318 For the full text of the H-Statements mentioned in this Section, see Section 16
2.2 Label elements
Labelling according to CLASS regulations 2013
Signal word
Danger Danger
Hazard statements
H315 Causes skin irritation. H318 Causes serious eye damage. none
Prevention
P264 Wash skin thoroughly after handling. P280 Wear protective gloves/ eye protection/ face protection.
Response
P302 + P352 IF ON SKIN: Wash with plenty of soap and water. P305 + P351 + P338 + IF IN EYES: Rinse cautiously with water for several minutes. P310 Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER or doctor/ physician. P332 + P313 If skin irritation occurs: Get medical advice/ attention. P362 Take off contaminated clothing and wash before reuse. Reduced Labeling (<= 125 ml)
Precautionary statements
none Refer to the Safety Data Sheet before use.
Other hazards
- none SECTION 3: Composition and information of the ingredients of the hazardous chemical
2.1 Classification of the substance or mixture
Classification according to CLASS regulations 2013 Skin corrosion/irritation (Category 2), H315 Serious eye damage/eye irritation (Category 1), H318 For the full text of the H-Statements mentioned in this Section, see Section 16.
